statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Early Detection Breakthrough: Biotech Companies Lead the Way in Pancreatic Cancer Treatment Early Detection Breakthrough: Biotech Companies Lead the Way in Pancreatic Cancer Treatment PR Newswire...

Early Detection Breakthrough: Biotech Companies Lead the Way in Pancreatic Cancer Treatment

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MacroGenics, Inc. - MGNX SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MacroGenics, Inc. - MGNX

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against MacroGenics, Inc. and Encourages Investors to Contact the Firm INVESTIGATION ALERT: The Schall Law Firm Announces...

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against MacroGenics, Inc. and Encourages Investors to Contact the Firm

The law firm of Kirby McInerney LLP is investigating potential claims against MacroGenics, Inc. (MacroGenics or the Company) (NASDAQ: MGNX). The investigation concerns whether MacroGenics and/or...

Kirby McInerney LLP Announces Investigation of Shareholder Claims Against MacroGenics, Inc. (MGNX)

Despite MacroGenics' clinical activity, unexpected adverse events raise concerns. Analysts adjust ratings and price targets.

 Latest Ratings for MGNX
 DateFirmActionFromTo Feb...

MacroGenics Gets Downgraded Following Disappointing Prostate Cancer Trial Results: 'We Were Surprised By Reported Deaths'

"Worst Case Scenario": MacroGenics Crashes After Five Patient Deaths In Experimental Drug Trial

 A Rockville, Maryland-based biotech company called MacroGenics crashed in premarket...

"Worst Case Scenario": MacroGenics Crashes After Five Patient Deaths In Experimental Drug Trial

Latest interim data from TAMARACK Phase 2 study by MacroGenics unveils insights into vobramitamab duocarmazine targeting B7-H3 in metastatic prostate cancer. Despite responses, notable safety...

MacroGenics Shares Tumble After Reporting Adverse Events, Multiple Deaths In Cancer Drug Trial

US Futures, Global Markets Storm Higher, Eye All-Time Highs

 US equity futures pointed to even more gains on the last day of trading, leaving the S&P 500 set for a third weekly rise the...

US Futures, Global Markets Storm Higher, Eye All-Time Highs

Biotech Innovations Aim to Combat Soaring Cancer Diagnoses by 2050 Biotech Innovations Aim to Combat Soaring Cancer Diagnoses by 2050 PR Newswire VANCOUVER, BC, May 1, 2024 USA News Group Commentary...

Biotech Innovations Aim to Combat Soaring Cancer Diagnoses by 2050

Update on MacroGenics Inc's Phase 2 TAMARACK study of vobramitamab duocarmazine (vobra duo) for metastatic castration-resistant prostate cancer (mCRPC). Safety and preliminary efficacy data...

MacroGenics Analyst Impressed By Improved Safety Profile From Prostate Cancer Candidate

MacroGenics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of antibody-based therapeutics for the treatment of cancer. Its product pipeline includes Margetuximab, Flotetuzumab, Retifanlimab, Enoblituzumab, Tebotelimab, MGC018, MGD019, IMGC936, and MGD014 for infectious diseases. The company was founded by Scott E. Koenig, Jeffrey V. Ravetch, LeRoy E. Hood, Ruedi Aebersold, and Alan Aderem on August 14, 2000 and is headquartered in Rockville, MD.

Watchers	4,219
52-Wk Low	$3.14
52-Wk High	$21.88

Volume	3.87M
52-Wk High	$21.88
52-Wk Low	$3.14

MGNX Macrogenics Inc

About

Feed

News

Sentiment

Earnings

Fundamentals

Sentiment

Message Volume

Community